Andrew C. Jackson - Chief Financial Officer at Ernexa Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
ERNA, ERNAW on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew C. Jackson since 24 May 2025

Holdings reported by Andrew C. Jackson for Ernexa Therapeutics Inc.

Form 4 holding Chief Financial Officer

Brooklyn ImmunoTherapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
664,800
Estimated value
Report date
03 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock, par value $0.005 per share
Underlying amount

Transactions reported by Andrew C. Jackson for Ernexa Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .